Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction.

Carro S, Bergo A, Mengoni M, Bachi A, Badaracco G, Kilstrup-Nielsen C, Landsberger N.

J Biol Chem. 2004 Jun 11;279(24):25623-31. Epub 2004 Mar 31.

2.

Functional consequences of Rett syndrome mutations on human MeCP2.

Yusufzai TM, Wolffe AP.

Nucleic Acids Res. 2000 Nov 1;28(21):4172-9.

3.

A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.

Buschdorf JP, Str├Ątling WH.

J Mol Med (Berl). 2004 Feb;82(2):135-43. Epub 2003 Nov 15.

PMID:
14618241
4.

A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.

Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR.

Mol Cell. 2003 Aug;12(2):425-35.

5.

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP.

Nat Genet. 1998 Jun;19(2):187-91.

PMID:
9620779
6.

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY.

Nat Genet. 1999 Oct;23(2):185-8.

PMID:
10508514
8.

Rett syndrome: a surprising result of mutation in MECP2.

Dragich J, Houwink-Manville I, Schanen C.

Hum Mol Genet. 2000 Oct;9(16):2365-75. Review.

PMID:
11005791
9.

Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.

Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Dragich J, Schanen C, Tamura M.

Brain Dev. 2001 Dec;23 Suppl 1:S165-73.

PMID:
11738866
10.

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A.

Nature. 1998 May 28;393(6683):386-9.

PMID:
9620804
11.
12.
13.

The Ski protein family is required for MeCP2-mediated transcriptional repression.

Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, Shinagawa T, Yasukawa T, Colmenares C, Ishii S.

J Biol Chem. 2001 Sep 7;276(36):34115-21. Epub 2001 Jul 5.

14.

Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.

Chen RZ, Akbarian S, Tudor M, Jaenisch R.

Nat Genet. 2001 Mar;27(3):327-31.

PMID:
11242118
15.

[Functional significance of MeCP2 mutations in patients with Rett syndrome].

Kudo S.

No To Hattatsu. 2002 May;34(3):224-9. Japanese.

PMID:
12030011
16.

Purification of MeCP2-containing deacetylase from Xenopus laevis.

Jones PL, Wade PA, Wolffe AP.

Methods Mol Biol. 2002;200:131-41. No abstract available.

PMID:
11951648
17.

MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.

Balmer D, Arredondo J, Samaco RC, LaSalle JM.

Hum Genet. 2002 Jun;110(6):545-52. Epub 2002 Apr 25.

PMID:
12107440
18.

Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.

Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Schanen C, Tamura M.

J Med Genet. 2003 Jul;40(7):487-93.

19.

Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A.

Hum Mol Genet. 2000 Apr 12;9(7):1119-29. Erratum in: Hum Mol Genet 2000 Jul 1;9(11):1717.

PMID:
10767337

Supplemental Content

Support Center